Retatrutide, also known as LY3437943, is an investigational synthetic peptide developed by Eli Lilly. It is classified as a triple receptor agonist that targets three pathways: GLP-1, GIP, and glucagon receptors.
$81.00
27 in stock
27 in stock
Retatrutide, also known as LY3437943, is an investigational synthetic and popular peptide developed by Eli Lilly. It is one of the popular peptides being studied in metabolic research. Retatrutide works as a triple receptor agonist. It targets GLP-1, GIP, and glucagon receptors.
Researchers study Retatrutide in areas such as obesity, type 2 diabetes, and other metabolic disorders. Research also covers conditions such as NAFLD and MASH. Eli Lilly continues to study Retatrutide in clinical trials.
Retatrutide is a long-acting peptide. Its half-life is about six days. Clinical research has studied subcutaneous administration with once-weekly dosing. The peptide is supplied as a lyophilized powder. Research samples may be tested for purity using HPLC.
As of 2026, Retatrutide remains in Phase 3 clinical development under the TRIUMPH program. It is not approved by the FDA, EMA, or MHRA. It is not approved for personal use, compounding, or general consumption. Retatrutide is intended for legitimate research, including laboratory studies, animal research, and approved human trials.| Retatrutide Compound | Price |
|---|---|
| Retatrutide Peptide 5 mg | $54 |
| Retatrutide Peptide 10 mg | $81 |
| Retatrutide Peptide 15 mg | $119 |
| Retatrutide 20 mg | $145 |
| Retatrutide 30 mg | $315 |
This compound is intended for laboratory research use only. It is not intended for human or animal consumption, or for use in diagnostic or therapeutic procedures.
| Property | Value |
|---|---|
| Molecular Formula | C221H342N46O68 |
| Molecular Mass | 4731 g/mol |
| Monoisotopic Mass | 4728.4717592 Da |
| Polar Area | 1780 Ų |
| Complexity | 11,500 |
| XLogP | -6.3 |
| Heavy Atom Count | 335 |
| Hydrogen Bond Donors | 58 |
| Hydrogen Bond Acceptors | 70 |
| Rotatable Bonds | 159 |
| PubChem CID | 171390338 |
| InChIKey | MLOLQJNKXBNWFW-SAGGEDDASA-N |
| IUPAC Name | 20-[[(1S)-4-[2-[2-[2-[[(5S)-5-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-5-amino-2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-2-methylpropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-2,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]hexanoyl]amino]-6-[[(2S)-1-[[(2S)-5-amino-1-[[1-[[(2S)-1-[[(2S)-1-[[(3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-2-oxoethyl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-6-oxohexyl]amino]-2-oxoethoxy]ethoxy]ethylamino]-1-carboxy-4-oxobutyl]amino]-20-oxoicosanoic acid |
| SMILES | CC[C@H](C)C(C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N[C@@H](CO)C(=O)N)NC(=O)[C@H](CC6=CC=CC=C6)NC(=O)[C@H](C)NC(=O)C(C)(C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)CC[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@](C)(CC(C)C)NC(=O)C([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CC=C(C=C7)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC8=CC=CC=C8)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)C(C)(C)NC(=O)[C@H](CC9=CC=C(C=C9)O)N |
Every batch of Buy Retatrutide – 10mg is tested for purity and identity using industry-standard methods.
High-Performance Liquid Chromatography confirms purity ≥99%. Each batch is analyzed to ensure consistent quality.
Identity verification via mass spectrometry confirms correct molecular weight of 4113.58 g/mol.
All compounds undergo independent third-party laboratory testing for quality assurance.
Certificate of Analysis documents are available for all compounds. Contact us with your order number to request batch-specific documentation.
Each compound batch is tested by independent laboratories to verify purity, identity, and quality. The Certificate of Analysis (COA) provides transparent lab results, ensuring the compound meets strict research-grade standards.
| Test | Method | Result | Specification | |
|---|---|---|---|---|
| Identity | HPLC-DAD | Retatrutide | Retatrutide | Pass |
| Purity | HPLC-DAD | 99.11 | >99% by HPLC | Pass |
| Quantity | HPLC Analyte Concentration Curve Assay | 10.11 | 10mg | Pass |
| Endotoxins | LAL ELISA | 0.103 EU/mL | ≤ 0.5 EU/mL | Pass |
| Sterility | Pour Plate | No Growth | No Growth | Pass |
